Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
PR Newswire, 810 Seventh Avenue, New York, NY 10019 - Monday 11 November 1996.
The company met November 8 with the Dermatologic and Ophthalmic Drugs Advisory Committee to the FDA. Following the closed meeting, Celgene Chairman and CEO John W. Jackson said his company will move ahead with submission plans and is hoping for a timely and favorable review.
Celgene has completed the pivotal trial for the use of thalidomide in AIDS-related cachexia, a severe weight loss and wasting condition. Assuming satisfactory safety and efficacy data, the company plans to move forward to submit an NDA in this indication also.
Celgene Corporation, headquartered in Warren, N.J., uses proprietary expertise in small molecule chemistry to serve the pharmaceutical and allied industries.
CONTACT: Bryan P. Murphy of M Booth & Associates, 212-481-7000; or Robert C. Butler, Chief Financial Officer of Celgene Corporation, 908-271-4102
Copyright (c) 1996/PR NewsWire. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Permissions Desk, PR Newswire, 810 Seventh Avenue, New York, NY 10019.
961111
PR961109
Copyright © 1996 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .